| Year |
Citation |
Score |
| 2024 |
Park JE, Kim TS, Zeng Y, Mikolaj M, Il Ahn J, Alam MS, Monnie CM, Shi V, Zhou M, Chun TW, Maldarelli F, Narayan K, Ahn J, Ashwell JD, Strebel K, et al. Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4 T cells. Nature Communications. 15: 2017. PMID 38443376 DOI: 10.1038/s41467-024-46306-8 |
0.433 |
|
| 2023 |
Gao C, Ouyang W, Kutza J, Grimm TA, Fields K, Lankford CSR, Schwartzkopff F, Paciga M, Stantchev T, Tiffany L, Strebel K, Clouse KA. Macrophage-Derived Factors with the Potential to Contribute to Pathogenicity of HIV-1 and HIV-2: Role of CCL-2/MCP-1. Viruses. 15. PMID 38005838 DOI: 10.3390/v15112160 |
0.424 |
|
| 2023 |
Saito H, Sukegawa S, Kao S, Strebel K. Human Mannose Receptor 1 Attenuates HIV-1 Infectivity in a Virus Isolate-Specific Manner. Viruses. 15. PMID 37896833 DOI: 10.3390/v15102057 |
0.466 |
|
| 2023 |
Lee K, Park JE, Kim TS, Zeng Y, Monnie C, Alam M, Zhou M, Mikolaj M, Maldarelli F, Narayan K, Ahn J, Ashwell J, Strebel K. Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells. Research Square. PMID 37645926 DOI: 10.21203/rs.3.rs-2924123/v1 |
0.43 |
|
| 2023 |
Fabryova H, Kao S, Sukegawa S, Miyagi E, Taylor L, Ferhadian D, Saito H, Schaal H, Hillebrand F, Strebel K. HIV-1 Vpr Induces Degradation of Gelsolin, a Myeloid Cell-Specific Host Factor That Reduces Viral Infectivity by Inhibiting the Expression and Packaging of the HIV-1 Env Glycoprotein. Mbio. e0297322. PMID 36602307 DOI: 10.1128/mbio.02973-22 |
0.51 |
|
| 2022 |
Kao S, Miyagi E, Mallorson R, Saito H, Sukegawa S, Mukherji A, Mateja A, Ferhadian D, Fabryova H, Clouse K, Strebel K. The Myeloid-Specific Transcription Factor PU.1 Upregulates Mannose Receptor Expression but Represses Basal Activity of the HIV-LTR Promoter. Journal of Virology. e0065222. PMID 35766490 DOI: 10.1128/jvi.00652-22 |
0.467 |
|
| 2021 |
Yao W, Strebel K, Yamaoka S, Yoshida T. SIVgsn-99CM71 Vpu employs different amino acids to antagonize human and greater spot-nosed monkey BST-2. Journal of Virology. JVI0152721. PMID 34878886 DOI: 10.1128/JVI.01527-21 |
0.362 |
|
| 2021 |
Bandarra S, Miyagi E, Ribeiro AC, Gonçalves J, Strebel K, Barahona I. APOBEC3B potently restricts HIV-2 but not HIV-1 in a Vif-dependent manner. Journal of Virology. JVI0117021. PMID 34523960 DOI: 10.1128/JVI.01170-21 |
0.437 |
|
| 2020 |
Krchlíková V, Fábryová H, Hron T, Young JM, Koslová A, Hejnar J, Strebel K, Elleder D. Antiviral Activity and Adaptive Evolution of Avian Tetherins. Journal of Virology. PMID 32238588 DOI: 10.1128/Jvi.00416-20 |
0.5 |
|
| 2020 |
Miyagi E, Welbourn S, Sukegawa S, Fabryova H, Kao S, Strebel K. Inhibition of Vif-mediated degradation of APOBEC3G through competitive binding of Core-binding factor beta (CBFβ). Journal of Virology. PMID 31941780 DOI: 10.1128/Jvi.01708-19 |
0.351 |
|
| 2019 |
Yao W, Yoshida T, Hashimoto S, Takeuchi H, Strebel K, Yamaoka S. Vpu of a simian immunodeficiency virus isolated from greater spot-nosed monkey antagonizes human BST-2 via two AxxxxxxxW motifs. Journal of Virology. PMID 31666374 DOI: 10.1128/Jvi.01669-19 |
0.535 |
|
| 2019 |
Fabryova H, Strebel K. Vpr and Its Cellular Interaction Partners: R We There Yet? Cells. 8. PMID 31652959 DOI: 10.3390/Cells8111310 |
0.479 |
|
| 2019 |
Stantchev TS, Zack-Taylor A, Mattson N, Strebel K, Broder CC, Clouse KA. Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages. Viruses. 11. PMID 31547585 DOI: 10.3390/V11100889 |
0.361 |
|
| 2018 |
Siddiqui R, Suzu S, Ueno M, Nasser H, Koba R, Bhuyan F, Noyori O, Hamidi S, Sheng G, Yasuda-Inoue M, Hishiki T, Sukegawa S, Miyagi E, Strebel K, Matsushita S, et al. Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages. Plos Pathogens. 14: e1007372. PMID 30496280 DOI: 10.1371/Journal.Ppat.1007372 |
0.532 |
|
| 2018 |
Kawano K, Doucet AJ, Ueno M, Kariya R, An W, Marzetta F, Kuroki M, Turelli P, Sukegawa S, Okada S, Strebel K, Trono D, Ariumi Y. HIV-1 Vpr and p21 restrict LINE-1 mobility. Nucleic Acids Research. PMID 30085096 DOI: 10.1093/Nar/Gky688 |
0.418 |
|
| 2018 |
Sukegawa S, Miyagi E, Bouamr F, Farkašová H, Strebel K. Mannose Receptor 1 Restricts HIV Particle Release from Infected Macrophages. Cell Reports. 22: 786-795. PMID 29346774 DOI: 10.1016/J.Celrep.2017.12.085 |
0.557 |
|
| 2017 |
Miyagi E, Kao S, Fumitaka M, Buckler-White A, Plishka R, Strebel K. Long-term passage of Vif-null HIV-1 in CD4(+) T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance. Virology. 504: 1-11. PMID 28131088 DOI: 10.1016/J.Virol.2017.01.016 |
0.494 |
|
| 2016 |
Chen CY, Shingai M, Welbourn S, Martin MA, Borrego P, Taveira N, Strebel K. Antagonism of BST-2/tetherin is a conserved function of the Env glycoprotein of primary HIV-2 isolates. Journal of Virology. PMID 27681141 DOI: 10.1128/Jvi.01451-16 |
0.528 |
|
| 2016 |
Matsuda K, Chen CY, Whitted S, Chertova E, Roser DJ, Wu F, Plishka RJ, Ourmanov I, Buckler-White A, Lifson JD, Strebel K, Hirsch VM. Enhanced antagonism of BST-2 by a neurovirulent SIV envelope. The Journal of Clinical Investigation. PMID 27159392 DOI: 10.1172/Jci83725 |
0.519 |
|
| 2016 |
Welbourn S, Strebel K. Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1. Virology. 488: 271-7. PMID 26655245 DOI: 10.1016/J.Virol.2015.11.022 |
0.381 |
|
| 2015 |
Hashimoto M, Nasser H, Bhuyan F, Kuse N, Satou Y, Harada S, Yoshimura K, Sakuragi JI, Monde K, Maeda Y, Welbourn S, Strebel K, Abd El-Wahab EW, Miyazaki M, Hattori S, et al. Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1. Journal of Immunology (Baltimore, Md. : 1950). PMID 26416279 DOI: 10.4049/Jimmunol.1500955 |
0.505 |
|
| 2015 |
Shingai M, Welbourn S, Brenchley JM, Acharya P, Miyagi E, Plishka RJ, Buckler-White A, Kwong PD, Nishimura Y, Strebel K, Martin MA. The Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4+ Memory T Cells. Plos Pathogens. 11: e1004928. PMID 25996507 DOI: 10.1371/Journal.Ppat.1004928 |
0.434 |
|
| 2015 |
Welbourn S, Kao S, Du Pont KE, Andrew AJ, Berndsen CE, Strebel K. Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2. The Journal of Biological Chemistry. 290: 3740-51. PMID 25525265 DOI: 10.1074/Jbc.M114.617639 |
0.462 |
|
| 2014 |
Klase Z, Yedavalli VS, Houzet L, Perkins M, Maldarelli F, Brenchley J, Strebel K, Liu P, Jeang KT. Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA. Plos Pathogens. 10: e1003997. PMID 24651404 DOI: 10.1371/Journal.Ppat.1003997 |
0.547 |
|
| 2014 |
Miyagi E, Kao S, Yedavalli V, Strebel K. CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G. Journal of Virology. 88: 4839-52. PMID 24522927 DOI: 10.1128/Jvi.03359-13 |
0.399 |
|
| 2014 |
Andrew A, Strebel K. HIV-1 accessory proteins: Vpu and Vif. Methods in Molecular Biology (Clifton, N.J.). 1087: 135-58. PMID 24158820 DOI: 10.1007/978-1-62703-670-2_12 |
0.544 |
|
| 2014 |
Strebel K. HIV-1 Vpu - an ion channel in search of a job. Biochimica Et Biophysica Acta. 1838: 1074-81. PMID 23831603 DOI: 10.1016/J.Bbamem.2013.06.029 |
0.469 |
|
| 2014 |
Edwards D, Strebel K, Parks RW, Pise-Masison C, Fenizia C, Fiocchi M, Franchini G. Role of regulatory proteins in HIV-1/HTLV-1 coinfection Retrovirology. 11: 122. DOI: 10.1186/1742-4690-11-S1-P122 |
0.511 |
|
| 2013 |
Strebel K. HIV accessory proteins versus host restriction factors. Current Opinion in Virology. 3: 692-9. PMID 24246762 DOI: 10.1016/j.coviro.2013.08.004 |
0.419 |
|
| 2013 |
Yoshida T, Koyanagi Y, Strebel K. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions. Journal of Virology. 87: 13825-36. PMID 24109238 DOI: 10.1128/Jvi.02567-13 |
0.536 |
|
| 2013 |
Welbourn S, Dutta SM, Semmes OJ, Strebel K. Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1. Journal of Virology. 87: 11516-24. PMID 23966382 DOI: 10.1128/Jvi.01642-13 |
0.513 |
|
| 2013 |
Sadjadpour R, Donau OK, Shingai M, Buckler-White A, Kao S, Strebel K, Nishimura Y, Martin MA. Emergence of gp120 V3 variants confers neutralization resistance in an R5 simian-human immunodeficiency virus-infected macaque elite neutralizer that targets the N332 glycan of the human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology. 87: 8798-804. PMID 23720719 DOI: 10.1128/Jvi.00878-13 |
0.476 |
|
| 2012 |
Gaur R, Strebel K. Insights into the dual activity of SIVmac239 Vif against human and African green monkey APOBEC3G. Plos One. 7: e48850. PMID 23189135 DOI: 10.1371/Journal.Pone.0048850 |
0.462 |
|
| 2012 |
Andrew AJ, Berndsen CE, Kao S, Strebel K. The size and conservation of a coiled-coil structure in the ectodomain of human BST-2/tetherin is dispensable for inhibition of HIV-1 virion release. The Journal of Biological Chemistry. 287: 44278-88. PMID 23152502 DOI: 10.1074/Jbc.M112.418822 |
0.423 |
|
| 2012 |
Welbourn S, Miyagi E, White TE, Diaz-Griffero F, Strebel K. Identification and characterization of naturally occurring splice variants of SAMHD1. Retrovirology. 9: 86. PMID 23092512 DOI: 10.1186/1742-4690-9-86 |
0.5 |
|
| 2012 |
Techtmann SM, Ghirlando R, Kao S, Strebel K, Maynard EL. Hydrodynamic and functional analysis of HIV-1 Vif oligomerization. Biochemistry. 51: 2078-86. PMID 22369580 DOI: 10.1021/Bi201738A |
0.45 |
|
| 2012 |
Iijima S, Lee YJ, Ode H, Arold ST, Kimura N, Yokoyama M, Sato H, Tanaka Y, Strebel K, Akari H. A noncanonical mu-1A-binding motif in the N terminus of HIV-1 Nef determines its ability to downregulate major histocompatibility complex class I in T lymphocytes. Journal of Virology. 86: 3944-51. PMID 22301137 DOI: 10.1128/Jvi.06257-11 |
0.423 |
|
| 2011 |
Andrew AJ, Kao S, Strebel K. C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif. The Journal of Biological Chemistry. 286: 39967-81. PMID 21937450 DOI: 10.1074/Jbc.M111.287011 |
0.446 |
|
| 2011 |
Miyagi E, Andrew A, Kao S, Yoshida T, Strebel K. Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells. Journal of Virology. 85: 11981-94. PMID 21917971 DOI: 10.1128/Jvi.05176-11 |
0.427 |
|
| 2011 |
Shingai M, Yoshida T, Martin MA, Strebel K. Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo. Journal of Virology. 85: 9708-15. PMID 21775449 DOI: 10.1128/Jvi.00626-11 |
0.609 |
|
| 2011 |
Yoshida T, Kao S, Strebel K. Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach. Frontiers in Microbiology. 2: 35. PMID 21687426 DOI: 10.3389/Fmicb.2011.00035 |
0.576 |
|
| 2011 |
Andrew AJ, Miyagi E, Strebel K. Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin. Journal of Virology. 85: 2611-9. PMID 21191020 DOI: 10.1128/Jvi.02080-10 |
0.52 |
|
| 2011 |
Andrew A, Strebel K. The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor? Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 31: 137-44. PMID 21166593 DOI: 10.1089/Jir.2010.0108 |
0.43 |
|
| 2011 |
Kobayashi T, Ode H, Yoshida T, Sato K, Gee P, Yamamoto SP, Ebina H, Strebel K, Sato H, Koyanagi Y. Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. Journal of Virology. 85: 932-45. PMID 21068238 DOI: 10.1128/Jvi.01668-10 |
0.506 |
|
| 2011 |
Giri K, Strebel K, Maynard EL. Biochemical and Biophysical Investigation of the Molecular Determinants of HIV-1 Vif Packaging Biophysical Journal. 100. DOI: 10.1016/J.Bpj.2010.12.1482 |
0.481 |
|
| 2010 |
Andrew A, Strebel K. HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms. Molecular Aspects of Medicine. 31: 407-17. PMID 20858517 DOI: 10.1016/J.Mam.2010.08.002 |
0.465 |
|
| 2010 |
Miyagi E, Brown CR, Opi S, Khan M, Goila-Gaur R, Kao S, Walker RC, Hirsch V, Strebel K. Stably expressed APOBEC3F has negligible antiviral activity. Journal of Virology. 84: 11067-75. PMID 20702622 DOI: 10.1128/Jvi.01249-10 |
0.457 |
|
| 2010 |
Sanville B, Dolan MA, Wollenberg K, Yan Y, Martin C, Yeung ML, Strebel K, Buckler-White A, Kozak CA. Adaptive evolution of Mus Apobec3 includes retroviral insertion and positive selection at two clusters of residues flanking the substrate groove. Plos Pathogens. 6: e1000974. PMID 20617165 DOI: 10.1371/Journal.Ppat.1000974 |
0.376 |
|
| 2010 |
Magadán JG, Pérez-Victoria FJ, Sougrat R, Ye Y, Strebel K, Bonifacino JS. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. Plos Pathogens. 6: e1000869. PMID 20442859 DOI: 10.1371/Journal.Ppat.1000869 |
0.408 |
|
| 2010 |
Walker RC, Khan MA, Kao S, Goila-Gaur R, Miyagi E, Strebel K. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif. Journal of Virology. 84: 5201-11. PMID 20219919 DOI: 10.1128/Jvi.02318-09 |
0.443 |
|
| 2010 |
Habermann A, Krijnse-Locker J, Oberwinkler H, Eckhardt M, Homann S, Andrew A, Strebel K, Kräusslich HG. CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. Journal of Virology. 84: 4646-58. PMID 20147389 DOI: 10.1128/Jvi.02421-09 |
0.476 |
|
| 2009 |
Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC, Strebel K. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization. Retrovirology. 6: 99. PMID 19886996 DOI: 10.1186/1742-4690-6-99 |
0.46 |
|
| 2009 |
Strebel K, Luban J, Jeang KT. Human cellular restriction factors that target HIV-1 replication. Bmc Medicine. 7: 48. PMID 19758442 DOI: 10.1186/1741-7015-7-48 |
0.504 |
|
| 2009 |
Andrew AJ, Miyagi E, Kao S, Strebel K. The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology. 6: 80. PMID 19737401 DOI: 10.1186/1742-4690-6-80 |
0.58 |
|
| 2009 |
Miyagi E, Andrew AJ, Kao S, Strebel K. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proceedings of the National Academy of Sciences of the United States of America. 106: 2868-73. PMID 19196977 DOI: 10.1073/Pnas.0813223106 |
0.486 |
|
| 2009 |
Goila-Gaur R, Khan MA, Miyagi E, Strebel K. Differential sensitivity of "old" versus "new" APOBEC3G to human immunodeficiency virus type 1 vif. Journal of Virology. 83: 1156-60. PMID 19004939 DOI: 10.1128/Jvi.01734-08 |
0.567 |
|
| 2009 |
Strebel K. Antagonizing the effects of Bst-2/tetherin: multiple ways to accomplish a common goal Retrovirology. 6: 1-1. DOI: 10.1186/1742-4690-6-S2-I10 |
0.583 |
|
| 2008 |
Watashi K, Khan M, Yedavalli VR, Yeung ML, Strebel K, Jeang KT. Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. Journal of Virology. 82: 9928-36. PMID 18684817 DOI: 10.1128/Jvi.01017-08 |
0.522 |
|
| 2008 |
Miyagi E, Schwartzkopff F, Plishka R, Buckler-White A, Clouse KA, Strebel K. APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages. Virology. 379: 266-74. PMID 18675436 DOI: 10.1016/J.Virol.2008.06.033 |
0.579 |
|
| 2008 |
Strebel K, Khan MA. APOBEC3G encapsidation into HIV-1 virions: which RNA is it? Retrovirology. 5: 55. PMID 18597677 DOI: 10.1186/1742-4690-5-55 |
0.381 |
|
| 2008 |
Goila-Gaur R, Strebel K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology. 5: 51. PMID 18577210 DOI: 10.1186/1742-4690-5-51 |
0.546 |
|
| 2008 |
Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology. 373: 85-97. PMID 18082865 DOI: 10.1016/J.Virol.2007.10.042 |
0.556 |
|
| 2008 |
Goila-Gaur R, Khan MA, Miyagi E, Kao S, Opi S, Takeuchi H, Strebel K. HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes. Virology. 372: 136-46. PMID 18023836 DOI: 10.1016/J.Virol.2007.10.017 |
0.468 |
|
| 2007 |
Miyagi E, Opi S, Takeuchi H, Khan M, Goila-Gaur R, Kao S, Strebel K. Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1. Journal of Virology. 81: 13346-53. PMID 17928335 DOI: 10.1128/Jvi.01361-07 |
0.455 |
|
| 2007 |
Kao S, Goila-Gaur R, Miyagi E, Khan MA, Opi S, Takeuchi H, Strebel K. Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif. Virology. 369: 329-39. PMID 17825339 DOI: 10.1016/J.Virol.2007.08.005 |
0.524 |
|
| 2007 |
Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity. Retrovirology. 4: 61. PMID 17727729 DOI: 10.1186/1742-4690-4-61 |
0.468 |
|
| 2007 |
Khan MA, Goila-Gaur R, Opi S, Miyagi E, Takeuchi H, Kao S, Strebel K. Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions. Retrovirology. 4: 48. PMID 17631688 DOI: 10.1186/1742-4690-4-48 |
0.417 |
|
| 2007 |
Strebel K. HIV accessory genes Vif and Vpu. Advances in Pharmacology (San Diego, Calif.). 55: 199-232. PMID 17586316 DOI: 10.1016/S1054-3589(07)55006-4 |
0.535 |
|
| 2007 |
Takeuchi H, Buckler-White A, Goila-Gaur R, Miyagi E, Khan MA, Opi S, Kao S, Sokolskaja E, Pertel T, Luban J, Strebel K. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells. Journal of Virology. 81: 8080-90. PMID 17522232 DOI: 10.1128/Jvi.02727-06 |
0.515 |
|
| 2007 |
Opi S, Kao S, Goila-Gaur R, Khan MA, Miyagi E, Takeuchi H, Strebel K. Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant. Journal of Virology. 81: 8236-46. PMID 17522211 DOI: 10.1128/Jvi.02694-06 |
0.504 |
|
| 2006 |
Iwatani Y, Takeuchi H, Strebel K, Levin JG. Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. Journal of Virology. 80: 5992-6002. PMID 16731938 DOI: 10.1128/Jvi.02680-05 |
0.358 |
|
| 2006 |
Opi S, Takeuchi H, Kao S, Khan MA, Miyagi E, Goila-Gaur R, Iwatani Y, Levin JG, Strebel K. Monomeric APOBEC3G is catalytically active and has antiviral activity. Journal of Virology. 80: 4673-82. PMID 16641260 DOI: 10.1128/Jvi.80.10.4673-4682.2006 |
0.511 |
|
| 2005 |
Hu K, Clément JF, Abrahamyan L, Strebel K, Bouvier M, Kleiman L, Mouland AJ. A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer. Journal of Virological Methods. 128: 93-103. PMID 15951029 DOI: 10.1016/J.Jviromet.2005.04.012 |
0.326 |
|
| 2005 |
Strebel K. APOBEC3G & HTLV-1: inhibition without deamination. Retrovirology. 2: 37. PMID 15921532 DOI: 10.1186/1742-4690-2-37 |
0.542 |
|
| 2005 |
Khan MA, Kao S, Miyagi E, Takeuchi H, Goila-Gaur R, Opi S, Gipson CL, Parslow TG, Ly H, Strebel K. Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes Journal of Virology. 79: 5870-5874. PMID 15827203 DOI: 10.1128/Jvi.79.9.5870-5874.2005 |
0.521 |
|
| 2005 |
Takeuchi H, Kao S, Miyagi E, Khan MA, Buckler-White A, Plishka R, Strebel K. Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G. The Journal of Biological Chemistry. 280: 375-82. PMID 15528183 DOI: 10.1074/Jbc.M408987200 |
0.561 |
|
| 2004 |
Fujita M, Akari H, Sakurai A, Yoshida A, Chiba T, Tanaka K, Strebel K, Adachi A. Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation. Microbes and Infection / Institut Pasteur. 6: 791-8. PMID 15374000 DOI: 10.1016/J.Micinf.2004.04.011 |
0.562 |
|
| 2004 |
Kao S, Miyagi E, Khan MA, Takeuchi H, Opi S, Goila-Gaur R, Strebel K. Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells. Retrovirology. 1: 27. PMID 15373943 DOI: 10.1186/1742-4690-1-27 |
0.497 |
|
| 2004 |
Strebel K. HIV-1 Vpu: putting a channel to the TASK. Molecular Cell. 14: 150-2. PMID 15099514 DOI: 10.1016/S1097-2765(04)00205-9 |
0.427 |
|
| 2004 |
Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proceedings of the National Academy of Sciences of the United States of America. 101: 5652-7. PMID 15054139 DOI: 10.1073/Pnas.0400830101 |
0.547 |
|
| 2004 |
Nguyen KL, Llano M, Akari H, Miyagi E, Poeschla EM, Strebel K, Bour S. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression Virology. 319: 163-175. PMID 15015498 DOI: 10.1016/J.Virol.2003.11.021 |
0.382 |
|
| 2004 |
Akari H, Fujita M, Kao S, Khan MA, Shehu-Xhilaga M, Adachi A, Strebel K. High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site. The Journal of Biological Chemistry. 279: 12355-62. PMID 14722068 DOI: 10.1074/Jbc.M312426200 |
0.473 |
|
| 2004 |
Markovic I, Stantchev TS, Fields KH, Tiffany LJ, Tomiç M, Weiss CD, Broder CC, Strebel K, Clouse KA. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood. 103: 1586-94. PMID 14592831 DOI: 10.1182/Blood-2003-05-1390 |
0.492 |
|
| 2003 |
Strebel K. Virus-host interactions: role of HIV proteins Vif, Tat, and Rev. Aids (London, England). 17: S25-34. PMID 15080177 DOI: 10.1097/00002030-200317004-00003 |
0.452 |
|
| 2003 |
Varthakavi V, Smith RM, Bour SP, Strebel K, Spearman P. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proceedings of the National Academy of Sciences of the United States of America. 100: 15154-9. PMID 14657387 DOI: 10.1073/Pnas.2433165100 |
0.52 |
|
| 2003 |
Kao S, Khan MA, Miyagi E, Plishka R, Buckler-White A, Strebel K. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. Journal of Virology. 77: 11398-407. PMID 14557625 DOI: 10.1128/Jvi.77.21.11398-11407.2003 |
0.595 |
|
| 2003 |
Bour S, Strebel K. The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release. Microbes and Infection. 5: 1029-39. PMID 12941395 DOI: 10.1016/S1286-4579(03)00191-6 |
0.576 |
|
| 2003 |
Bour S, Akari H, Miyagi E, Strebel K. Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release. Virology. 309: 85-98. PMID 12726729 DOI: 10.1016/S0042-6822(02)00128-9 |
0.566 |
|
| 2003 |
Kao S, Akari H, Khan MA, Dettenhofer M, Yu XF, Strebel K. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection. Journal of Virology. 77: 1131-40. PMID 12502829 DOI: 10.1128/Jvi.77.2.1131-1140.2003 |
0.459 |
|
| 2002 |
Khan MA, Akari H, Kao S, Aberham C, Davis D, Buckler-White A, Strebel K. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function. Journal of Virology. 76: 9112-23. PMID 12186895 DOI: 10.1128/Jvi.76.18.9112-9123.2002 |
0.524 |
|
| 2002 |
Ma C, Marassi FM, Jones DH, Straus SK, Bour S, Strebel K, Schubert U, Oblatt-Montal M, Montal M, Opella SJ. Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1. Protein Science : a Publication of the Protein Society. 11: 546-57. PMID 11847278 DOI: 10.1110/Ps.37302 |
0.462 |
|
| 2001 |
Akari H, Bour S, Kao S, Adachi A, Strebel K. The Human Immunodeficiency Virus Type 1 Accessory Protein Vpu Induces Apoptosis by Suppressing the Nuclear Factor κB–dependent Expression of Antiapoptotic Factors Journal of Experimental Medicine. 194: 1299-1312. PMID 11696595 DOI: 10.1084/Jem.194.9.1299 |
0.449 |
|
| 2001 |
Khan MA, Aberham C, Kao S, Akari H, Gorelick R, Bour S, Strebel K. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA Journal of Virology. 75: 7252-7265. PMID 11461998 DOI: 10.1128/Jvi.75.16.7252-7265.2001 |
0.515 |
|
| 2001 |
Bour S, Perrin C, Akari H, Strebel K. The Human Immunodeficiency Virus Type 1 Vpu Protein Inhibits NF-κB Activation by Interfering with βTrCP-mediated Degradation of IκB Journal of Biological Chemistry. 276: 15920-15928. PMID 11278695 DOI: 10.1074/Jbc.M010533200 |
0.523 |
|
| 2000 |
Bour S, Strebel K. HIV accessory proteins: Multifunctional components of a complex system Advances in Pharmacology. 48: 75-120. PMID 10987089 DOI: 10.1016/S1054-3589(00)48004-X |
0.446 |
|
| 2000 |
Akari H, Arold S, Fukumori T, Okazaki T, Strebel K, Adachi A. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. Journal of Virology. 74: 2907-2912. PMID 10684310 DOI: 10.1128/Jvi.74.6.2907-2912.2000 |
0.468 |
|
| 1999 |
Marassi FM, Ma C, Gratkowski H, Straus SK, Strebel K, Oblatt-Montal M, Montal M, Opella SJ. Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 96: 14336-41. PMID 10588706 DOI: 10.1073/Pnas.96.25.14336 |
0.326 |
|
| 1999 |
Bour S, Perrin C, Strebel K. Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. Journal of Biological Chemistry. 274: 33800-33806. PMID 10559275 DOI: 10.1074/Jbc.274.47.33800 |
0.466 |
|
| 1999 |
Lin Z, Neamati N, Zhao H, Kiryu Y, Turpin JA, Aberham C, Strebel K, Kohn K, Witvrouw M, Pannecouque C, Debyser Z, De Clercq E, Rice WG, Pommier Y, Burke TR. Chicoric acid analogues as HIV-1 integrase inhibitors. Journal of Medicinal Chemistry. 42: 1401-14. PMID 10212126 DOI: 10.1021/Jm980531M |
0.484 |
|
| 1999 |
Schubert U, Bour S, Willey RL, Strebel K. Regulation of Virus Release by the Macrophage-Tropic Human Immunodeficiency Virus Type 1 AD8 Isolate Is Redundant and Can Be Controlled by either Vpu or Env Journal of Virology. 73: 887-896. PMID 9882289 DOI: 10.1128/Jvi.73.2.887-896.1999 |
0.529 |
|
| 1999 |
Bour SP, Aberham C, Perrin C, Strebel K. Lack of Effect of Cytoplasmic Tail Truncations on Human Immunodeficiency Virus Type 2 ROD Env Particle Release Activity Journal of Virology. 73: 778-782. PMID 9847387 DOI: 10.1128/Jvi.73.1.778-782.1999 |
0.55 |
|
| 1998 |
Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R. A Novel Human WD Protein, h-βTrCP, that Interacts with HIV-1 Vpu Connects CD4 to the ER Degradation Pathway through an F-Box Motif Molecular Cell. 1: 565-574. PMID 9660940 DOI: 10.1016/S1097-2765(00)80056-8 |
0.406 |
|
| 1998 |
Schubert U, Antón LC, Bačík I, Cox JH, Bour S, Bennink JR, Orlowski M, Strebel K, Yewdell JW. CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway Journal of Virology. 72: 2280-2288. PMID 9499087 DOI: 10.1128/Jvi.72.3.2280-2288.1998 |
0.436 |
|
| 1997 |
Bour S, Strebel K. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. Journal of Virology. 70: 8285-300. PMID 8970948 DOI: 10.1128/jvi.70.12.8285-8300.1996 |
0.486 |
|
| 1996 |
Schubert U, Ferrer-Montiel AV, Oblatt-Montal M, Henklein P, Strebel K, Montal M. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. Febs Letters. 398: 12-8. PMID 8946945 DOI: 10.1016/S0014-5793(96)01146-5 |
0.435 |
|
| 1996 |
Bour S, Schubert U, Peden K, Strebel K. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? Journal of Virology. 70: 820-829. PMID 8551620 DOI: 10.1128/Jvi.70.2.820-829.1996 |
0.557 |
|
| 1996 |
Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. Journal of Virology. 70: 809-19. PMID 8551619 DOI: 10.1128/Jvi.70.2.809-819.1996 |
0.548 |
|
| 1996 |
Karczewski MK, Strebel K. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. Journal of Virology. 70: 494-507. PMID 8523563 DOI: 10.1128/jvi.70.1.494-507.1996 |
0.447 |
|
| 1995 |
Bour S, Schubert U, Strebel K. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. Journal of Virology. 69: 1510-1520. PMID 7853484 DOI: 10.1128/Jvi.69.3.1510-1520.1995 |
0.331 |
|
| 1995 |
Schubert U, Clouse KA, Strebel K. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. Journal of Virology. 69: 7699-7711. PMID 7494279 DOI: 10.1128/Jvi.69.12.7699-7711.1995 |
0.497 |
|
| 1994 |
Willey RL, Buckler-White A, Strebel K. Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein. Journal of Virology. 68: 1207-1212. PMID 8289353 DOI: 10.1128/Jvi.68.2.1207-1212.1994 |
0.401 |
|
| 1994 |
Schubert U, Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. Journal of Virology. 68: 2260-71. PMID 8139011 DOI: 10.1128/jvi.68.4.2260-2271.1994 |
0.494 |
|
| 1994 |
Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. Journal of Molecular Biology. 236: 16-25. PMID 8107101 DOI: 10.1006/Jmbi.1994.1114 |
0.388 |
|
| 1993 |
Chen M, Maldarelli F, Karczewski MK, Willey RL, Strebel K. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro : the cytoplasmic domain of CD4 contributes to Vpu sensitivity Journal of Virology. 67: 3877-3884. PMID 8510209 DOI: 10.1128/Jvi.67.7.3877-3884.1993 |
0.454 |
|
| 1993 |
Howcroft TK, Strebel K, Martin MA, Singer DS. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science (New York, N.Y.). 260: 1320-2. PMID 8493575 DOI: 10.1126/SCIENCE.8493575 |
0.466 |
|
| 1993 |
Maldarelli F, Chen M, Willey RL, Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. Journal of Virology. 67: 5056-5061. PMID 8331740 DOI: 10.1128/Jvi.67.8.5056-5061.1993 |
0.408 |
|
| 1992 |
Willey RL, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. Journal of Virology. 66: 226-234. PMID 1727486 DOI: 10.1128/Jvi.66.1.226-234.1992 |
0.432 |
|
| 1992 |
Willey RL, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. Journal of Virology. 66: 7193-7200. PMID 1433512 DOI: 10.1128/Jvi.66.12.7193-7200.1992 |
0.44 |
|
| 1991 |
Maldarelli F, Martin MA, Strebel K. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. Journal of Virology. 65: 5732-5743. PMID 1656066 DOI: 10.1128/Jvi.65.11.5732-5743.1991 |
0.444 |
|
| 1990 |
Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. Journal of Virology. 64: 621-629. PMID 2404139 DOI: 10.1128/Jvi.64.2.621-629.1990 |
0.492 |
|
| 1990 |
Zibert A, Maass G, Strebel K, Falk MM, Beck E. Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. Journal of Virology. 64: 2467-73. PMID 2159523 DOI: 10.1128/Jvi.64.6.2467-2473.1990 |
0.309 |
|
| 1989 |
Clavel F, Hoggan MD, Willey RL, Strebel K, Martin MA, Repaske R. Genetic recombination of human immunodeficiency virus. Journal of Virology. 63: 1455-1459. PMID 2915387 DOI: 10.1128/Jvi.63.3.1455-1459.1989 |
0.537 |
|
| 1989 |
Strebel K, Klimkait T, Maldarelli F, Martin MA. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. Journal of Virology. 63: 3784-3791. PMID 2788224 DOI: 10.1128/Jvi.63.9.3784-3791.1989 |
0.573 |
|
| 1988 |
Strebel K, Klimkait T, Martin MA. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 241: 1221-1223. PMID 3261888 DOI: 10.1126/Science.3261888 |
0.532 |
|
| 1987 |
Strebel K, Daugherty D, Clouse K, Cohen D, Folks T, Martin MA. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature. 328: 728-30. PMID 2441266 DOI: 10.1038/328728A0 |
0.572 |
|
| 1986 |
Strebel K, Beck E, Strohmaier K, Schaller H. Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. Journal of Virology. 57: 983-991. DOI: 10.1128/Jvi.57.3.983-991.1986 |
0.375 |
|
| 1984 |
Forss S, Strebel K, Beck E, Schaller H. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Research. 12: 6587-601. PMID 6089122 DOI: 10.1093/Nar/12.16.6587 |
0.341 |
|
| 1983 |
Beck E, Forss S, Strebel K, Cattaneo R, Feil G. Structure of the FMDV translation initiation site and of the structural proteins Nucleic Acids Research. 11: 7873-7885. PMID 6316275 DOI: 10.1093/Nar/11.22.7873 |
0.346 |
|
| Show low-probability matches. |
